Choreo LLC’s Dynavax Technologies DVAX Stock Holding History

Choreo LLC’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-41,417	Closed	-$637K	–	1636
2025 Q4	$637K	Sell	41,417 -1,585	-4%	-$17.5K	0.01%	813
2025 Q3	$427K	Buy	43,002 +9,867	+30%	+$103K	0.01%	1008
2025 Q2	$329K	Sell	33,135 -1,693	-5%	-$17.8K	﹤0.01%	1119
2025 Q1	$452K	Buy	34,828 +1,065	+3%	+$14.1K	0.01%	888
2024 Q4	$433K	Sell	33,763 -676	-2%	-$8.18K	0.01%	982
2024 Q3	$389K	Buy	34,439 +1,924	+6%	+$21.2K	0.01%	1039
2024 Q2	$363K	Buy	+32,515	New	+$378K	0.01%	989

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Choreo LLC's DVAX Position: Q1 2026 in Review

Choreo LLC sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 41,417 shares — an estimated $637K sold.

Choreo LLC first reported a position in DVAX in Q2 2024 and held it in 7 quarters. The position peaked at $637K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

Choreo LLC reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
Choreo LLC sold 41,417 Dynavax Technologies shares in Q1 2026, an estimated $637K.
Choreo LLC first reported a position in Dynavax Technologies in Q2 2024 and held it in 7 quarters.
Choreo LLC's Dynavax Technologies position peaked at $637K in Q4 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.